We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Procedures to assess the quality of mammographic x-ray equipment used in NHS breast screening.
Directions relating to the exercise of powers under section 7(2) and (7A) of the Health and Medicines Act 1988 by means of forming or participating in companies.
Evidence-based principles for the effective use of screening appointment text message reminders in reducing inequalities and supporting informed choice.
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
How health app content should be reviewed by subject matter experts.
Technical specification and associated documents for individual care accounts, allowing local authorities to monitor a person's progress towards the lifetime cap on care costs.
The NHS breast screening programme's specification for mobile breast screening units (MBSUs), also called mobile digital trailers.
Sets out how the NHS should engage with researchers and innovators when entering into data partnerships to benefit patients and the NHS.
Guidance on what you need to consider when developing and submitting a health app for assessment.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatmen…
VDEC’s Discovery and surveillance capabilities provide unique services across a spectrum of molecular immunology platforms.
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Information on medical facilities available in Timor-Leste.
Guidance on health app assessment bodies and what to consider when selecting one.
UKHSA offers a unique opportunity to harness world-class intellectual, scientific, and operational expertise for public health solutions.
VDEC provides a number of services for vaccines post-licensure
This report considers the results of an intercomparison conducted in 2018, in which 26 laboratories from 12 countries submitted 30 sets of detectors.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).